nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—Cytochrome P450 3A4 Inhibitors—Ticagrelor—coronary artery disease	0.418	1	CiPCiCtD
Efavirenz—CYP2C19—coronary artery disease	0.128	1	CbGaD
Efavirenz—CYP2B6—Clopidogrel—coronary artery disease	0.0169	0.0534	CbGbCtD
Efavirenz—CYP2C9—Fenofibrate—coronary artery disease	0.0129	0.0407	CbGbCtD
Efavirenz—CYP2C19—Gemfibrozil—coronary artery disease	0.0124	0.0391	CbGbCtD
Efavirenz—CYP1A2—Gemfibrozil—coronary artery disease	0.0114	0.0361	CbGbCtD
Efavirenz—CYP2C19—Clopidogrel—coronary artery disease	0.0107	0.0339	CbGbCtD
Efavirenz—CYP2C9—Gemfibrozil—coronary artery disease	0.0103	0.0325	CbGbCtD
Efavirenz—CYP2B6—Simvastatin—coronary artery disease	0.0101	0.032	CbGbCtD
Efavirenz—CYP1A2—Clopidogrel—coronary artery disease	0.00989	0.0313	CbGbCtD
Efavirenz—CYP2C19—Telmisartan—coronary artery disease	0.00937	0.0296	CbGbCtD
Efavirenz—CYP2B6—Atorvastatin—coronary artery disease	0.00901	0.0285	CbGbCtD
Efavirenz—CYP2C9—Clopidogrel—coronary artery disease	0.00891	0.0282	CbGbCtD
Efavirenz—CYP3A4—Ticagrelor—coronary artery disease	0.00839	0.0265	CbGbCtD
Efavirenz—CYP2C9—Pitavastatin—coronary artery disease	0.00779	0.0246	CbGbCtD
Efavirenz—CYP2C9—Valsartan—coronary artery disease	0.00758	0.024	CbGbCtD
Efavirenz—CYP2C19—Timolol—coronary artery disease	0.00755	0.0239	CbGbCtD
Efavirenz—CYP3A4—Fenofibrate—coronary artery disease	0.00748	0.0236	CbGbCtD
Efavirenz—CYP2C19—Rosuvastatin—coronary artery disease	0.00691	0.0219	CbGbCtD
Efavirenz—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00673	0.0213	CbGbCtD
Efavirenz—CYP2C19—Simvastatin—coronary artery disease	0.00642	0.0203	CbGbCtD
Efavirenz—CYP2C19—Lovastatin—coronary artery disease	0.00629	0.0199	CbGbCtD
Efavirenz—CYP2D6—Niacin—coronary artery disease	0.00618	0.0195	CbGbCtD
Efavirenz—CYP3A4—Gemfibrozil—coronary artery disease	0.00598	0.0189	CbGbCtD
Efavirenz—CYP2C9—Rosuvastatin—coronary artery disease	0.00574	0.0182	CbGbCtD
Efavirenz—CYP2D6—Timolol—coronary artery disease	0.00574	0.0182	CbGbCtD
Efavirenz—CYP2C19—Atorvastatin—coronary artery disease	0.00572	0.0181	CbGbCtD
Efavirenz—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.0056	0.0177	CbGbCtD
Efavirenz—CYP2C9—Simvastatin—coronary artery disease	0.00534	0.0169	CbGbCtD
Efavirenz—CYP2C19—Losartan—coronary artery disease	0.00524	0.0166	CbGbCtD
Efavirenz—CYP2C9—Pravastatin—coronary artery disease	0.00523	0.0165	CbGbCtD
Efavirenz—CYP2C9—Lovastatin—coronary artery disease	0.00523	0.0165	CbGbCtD
Efavirenz—CYP3A4—Clopidogrel—coronary artery disease	0.00518	0.0164	CbGbCtD
Efavirenz—CYP2D6—Captopril—coronary artery disease	0.00506	0.016	CbGbCtD
Efavirenz—CYP2D6—Simvastatin—coronary artery disease	0.00488	0.0154	CbGbCtD
Efavirenz—CYP1A2—Losartan—coronary artery disease	0.00483	0.0153	CbGbCtD
Efavirenz—CYP3A4—Eplerenone—coronary artery disease	0.00482	0.0152	CbGbCtD
Efavirenz—CYP2D6—Pravastatin—coronary artery disease	0.00478	0.0151	CbGbCtD
Efavirenz—CYP2D6—Lovastatin—coronary artery disease	0.00478	0.0151	CbGbCtD
Efavirenz—CYP2C9—Atorvastatin—coronary artery disease	0.00476	0.0151	CbGbCtD
Efavirenz—CYP2C9—Losartan—coronary artery disease	0.00435	0.0138	CbGbCtD
Efavirenz—CYP2D6—Atorvastatin—coronary artery disease	0.00435	0.0138	CbGbCtD
Efavirenz—CYP3A4—Enalapril—coronary artery disease	0.00429	0.0136	CbGbCtD
Efavirenz—CYP3A4—Rosuvastatin—coronary artery disease	0.00334	0.0106	CbGbCtD
Efavirenz—CYP3A4—Ezetimibe—coronary artery disease	0.00334	0.0106	CbGbCtD
Efavirenz—CYP3A4—Simvastatin—coronary artery disease	0.00311	0.00982	CbGbCtD
Efavirenz—CYP3A4—Pravastatin—coronary artery disease	0.00304	0.00961	CbGbCtD
Efavirenz—CYP3A4—Lovastatin—coronary artery disease	0.00304	0.00961	CbGbCtD
Efavirenz—CYP3A4—Atorvastatin—coronary artery disease	0.00277	0.00875	CbGbCtD
Efavirenz—CYP3A4—Losartan—coronary artery disease	0.00253	0.00801	CbGbCtD
Efavirenz—Decreased appetite—Losartan—coronary artery disease	2.89e-05	0.000247	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	2.89e-05	0.000247	CcSEcCtD
Efavirenz—Abdominal pain—Captopril—coronary artery disease	2.89e-05	0.000247	CcSEcCtD
Efavirenz—Body temperature increased—Captopril—coronary artery disease	2.89e-05	0.000247	CcSEcCtD
Efavirenz—Dizziness—Simvastatin—coronary artery disease	2.88e-05	0.000246	CcSEcCtD
Efavirenz—Rash—Ezetimibe—coronary artery disease	2.88e-05	0.000246	CcSEcCtD
Efavirenz—Dermatitis—Ezetimibe—coronary artery disease	2.87e-05	0.000246	CcSEcCtD
Efavirenz—Confusional state—Ramipril—coronary artery disease	2.87e-05	0.000246	CcSEcCtD
Efavirenz—Discomfort—Timolol—coronary artery disease	2.87e-05	0.000245	CcSEcCtD
Efavirenz—Asthenia—Niacin—coronary artery disease	2.87e-05	0.000245	CcSEcCtD
Efavirenz—Fatigue—Losartan—coronary artery disease	2.87e-05	0.000245	CcSEcCtD
Efavirenz—Headache—Ezetimibe—coronary artery disease	2.86e-05	0.000244	CcSEcCtD
Efavirenz—Malaise—Lisinopril—coronary artery disease	2.86e-05	0.000244	CcSEcCtD
Efavirenz—Vertigo—Lisinopril—coronary artery disease	2.85e-05	0.000243	CcSEcCtD
Efavirenz—Dry mouth—Timolol—coronary artery disease	2.84e-05	0.000243	CcSEcCtD
Efavirenz—Constipation—Losartan—coronary artery disease	2.84e-05	0.000243	CcSEcCtD
Efavirenz—Pain—Losartan—coronary artery disease	2.84e-05	0.000243	CcSEcCtD
Efavirenz—Syncope—Lisinopril—coronary artery disease	2.84e-05	0.000243	CcSEcCtD
Efavirenz—Vomiting—Eplerenone—coronary artery disease	2.84e-05	0.000243	CcSEcCtD
Efavirenz—Feeling abnormal—Furosemide—coronary artery disease	2.84e-05	0.000243	CcSEcCtD
Efavirenz—Nausea—Fenofibrate—coronary artery disease	2.83e-05	0.000242	CcSEcCtD
Efavirenz—Pruritus—Niacin—coronary artery disease	2.83e-05	0.000242	CcSEcCtD
Efavirenz—Asthenia—Pravastatin—coronary artery disease	2.82e-05	0.000241	CcSEcCtD
Efavirenz—Gastrointestinal pain—Furosemide—coronary artery disease	2.82e-05	0.000241	CcSEcCtD
Efavirenz—Rash—Eplerenone—coronary artery disease	2.82e-05	0.000241	CcSEcCtD
Efavirenz—Urticaria—Perindopril—coronary artery disease	2.82e-05	0.000241	CcSEcCtD
Efavirenz—Hypersensitivity—Trandolapril—coronary artery disease	2.82e-05	0.000241	CcSEcCtD
Efavirenz—Dermatitis—Eplerenone—coronary artery disease	2.81e-05	0.00024	CcSEcCtD
Efavirenz—Diarrhoea—Valsartan—coronary artery disease	2.81e-05	0.00024	CcSEcCtD
Efavirenz—Confusional state—Timolol—coronary artery disease	2.81e-05	0.00024	CcSEcCtD
Efavirenz—Shock—Ramipril—coronary artery disease	2.8e-05	0.00024	CcSEcCtD
Efavirenz—Hypersensitivity—Enalapril—coronary artery disease	2.8e-05	0.00024	CcSEcCtD
Efavirenz—Body temperature increased—Perindopril—coronary artery disease	2.8e-05	0.000239	CcSEcCtD
Efavirenz—Abdominal pain—Perindopril—coronary artery disease	2.8e-05	0.000239	CcSEcCtD
Efavirenz—Palpitations—Lisinopril—coronary artery disease	2.8e-05	0.000239	CcSEcCtD
Efavirenz—Diarrhoea—Olmesartan—coronary artery disease	2.8e-05	0.000239	CcSEcCtD
Efavirenz—Headache—Eplerenone—coronary artery disease	2.8e-05	0.000239	CcSEcCtD
Efavirenz—Nervous system disorder—Ramipril—coronary artery disease	2.8e-05	0.000239	CcSEcCtD
Efavirenz—Thrombocytopenia—Ramipril—coronary artery disease	2.79e-05	0.000238	CcSEcCtD
Efavirenz—Pruritus—Pravastatin—coronary artery disease	2.78e-05	0.000238	CcSEcCtD
Efavirenz—Loss of consciousness—Lisinopril—coronary artery disease	2.78e-05	0.000238	CcSEcCtD
Efavirenz—Nausea—Clopidogrel—coronary artery disease	2.78e-05	0.000238	CcSEcCtD
Efavirenz—Tachycardia—Ramipril—coronary artery disease	2.78e-05	0.000238	CcSEcCtD
Efavirenz—Skin disorder—Ramipril—coronary artery disease	2.77e-05	0.000237	CcSEcCtD
Efavirenz—Vomiting—Simvastatin—coronary artery disease	2.77e-05	0.000236	CcSEcCtD
Efavirenz—Hypersensitivity—Telmisartan—coronary artery disease	2.77e-05	0.000236	CcSEcCtD
Efavirenz—Cough—Lisinopril—coronary artery disease	2.76e-05	0.000236	CcSEcCtD
Efavirenz—Nausea—Lovastatin—coronary artery disease	2.76e-05	0.000236	CcSEcCtD
Efavirenz—Hyperhidrosis—Ramipril—coronary artery disease	2.76e-05	0.000235	CcSEcCtD
Efavirenz—Rash—Simvastatin—coronary artery disease	2.74e-05	0.000234	CcSEcCtD
Efavirenz—Dermatitis—Simvastatin—coronary artery disease	2.74e-05	0.000234	CcSEcCtD
Efavirenz—Asthenia—Trandolapril—coronary artery disease	2.74e-05	0.000234	CcSEcCtD
Efavirenz—Shock—Timolol—coronary artery disease	2.74e-05	0.000234	CcSEcCtD
Efavirenz—Feeling abnormal—Losartan—coronary artery disease	2.74e-05	0.000234	CcSEcCtD
Efavirenz—Urticaria—Furosemide—coronary artery disease	2.74e-05	0.000234	CcSEcCtD
Efavirenz—Diarrhoea—Niacin—coronary artery disease	2.73e-05	0.000234	CcSEcCtD
Efavirenz—Nervous system disorder—Timolol—coronary artery disease	2.73e-05	0.000234	CcSEcCtD
Efavirenz—Asthenia—Enalapril—coronary artery disease	2.73e-05	0.000233	CcSEcCtD
Efavirenz—Headache—Simvastatin—coronary artery disease	2.73e-05	0.000233	CcSEcCtD
Efavirenz—Abdominal pain—Furosemide—coronary artery disease	2.72e-05	0.000233	CcSEcCtD
Efavirenz—Body temperature increased—Furosemide—coronary artery disease	2.72e-05	0.000233	CcSEcCtD
Efavirenz—Gastrointestinal pain—Losartan—coronary artery disease	2.72e-05	0.000232	CcSEcCtD
Efavirenz—Dizziness—Valsartan—coronary artery disease	2.72e-05	0.000232	CcSEcCtD
Efavirenz—Anorexia—Ramipril—coronary artery disease	2.72e-05	0.000232	CcSEcCtD
Efavirenz—Nausea—Ezetimibe—coronary artery disease	2.71e-05	0.000232	CcSEcCtD
Efavirenz—Skin disorder—Timolol—coronary artery disease	2.71e-05	0.000231	CcSEcCtD
Efavirenz—Dizziness—Olmesartan—coronary artery disease	2.7e-05	0.000231	CcSEcCtD
Efavirenz—Pruritus—Trandolapril—coronary artery disease	2.7e-05	0.000231	CcSEcCtD
Efavirenz—Arthralgia—Lisinopril—coronary artery disease	2.7e-05	0.00023	CcSEcCtD
Efavirenz—Chest pain—Lisinopril—coronary artery disease	2.7e-05	0.00023	CcSEcCtD
Efavirenz—Myalgia—Lisinopril—coronary artery disease	2.7e-05	0.00023	CcSEcCtD
Efavirenz—Hyperhidrosis—Timolol—coronary artery disease	2.69e-05	0.00023	CcSEcCtD
Efavirenz—Asthenia—Telmisartan—coronary artery disease	2.69e-05	0.00023	CcSEcCtD
Efavirenz—Pruritus—Enalapril—coronary artery disease	2.69e-05	0.00023	CcSEcCtD
Efavirenz—Diarrhoea—Pravastatin—coronary artery disease	2.69e-05	0.00023	CcSEcCtD
Efavirenz—Anxiety—Lisinopril—coronary artery disease	2.69e-05	0.00023	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.68e-05	0.000229	CcSEcCtD
Efavirenz—Discomfort—Lisinopril—coronary artery disease	2.66e-05	0.000228	CcSEcCtD
Efavirenz—Anorexia—Timolol—coronary artery disease	2.66e-05	0.000227	CcSEcCtD
Efavirenz—Pruritus—Telmisartan—coronary artery disease	2.66e-05	0.000227	CcSEcCtD
Efavirenz—Nausea—Eplerenone—coronary artery disease	2.65e-05	0.000227	CcSEcCtD
Efavirenz—Dizziness—Niacin—coronary artery disease	2.64e-05	0.000226	CcSEcCtD
Efavirenz—Urticaria—Losartan—coronary artery disease	2.64e-05	0.000226	CcSEcCtD
Efavirenz—Dry mouth—Lisinopril—coronary artery disease	2.64e-05	0.000225	CcSEcCtD
Efavirenz—Body temperature increased—Losartan—coronary artery disease	2.63e-05	0.000225	CcSEcCtD
Efavirenz—Abdominal pain—Losartan—coronary artery disease	2.63e-05	0.000225	CcSEcCtD
Efavirenz—Asthenia—Captopril—coronary artery disease	2.62e-05	0.000224	CcSEcCtD
Efavirenz—Diarrhoea—Trandolapril—coronary artery disease	2.61e-05	0.000223	CcSEcCtD
Efavirenz—Vomiting—Valsartan—coronary artery disease	2.61e-05	0.000223	CcSEcCtD
Efavirenz—Confusional state—Lisinopril—coronary artery disease	2.61e-05	0.000223	CcSEcCtD
Efavirenz—Diarrhoea—Enalapril—coronary artery disease	2.6e-05	0.000223	CcSEcCtD
Efavirenz—Dizziness—Pravastatin—coronary artery disease	2.6e-05	0.000222	CcSEcCtD
Efavirenz—Vomiting—Olmesartan—coronary artery disease	2.6e-05	0.000222	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.6e-05	0.000222	CcSEcCtD
Efavirenz—Rash—Valsartan—coronary artery disease	2.59e-05	0.000221	CcSEcCtD
Efavirenz—Dermatitis—Valsartan—coronary artery disease	2.59e-05	0.000221	CcSEcCtD
Efavirenz—Nausea—Simvastatin—coronary artery disease	2.59e-05	0.000221	CcSEcCtD
Efavirenz—Pruritus—Captopril—coronary artery disease	2.58e-05	0.000221	CcSEcCtD
Efavirenz—Rash—Olmesartan—coronary artery disease	2.58e-05	0.00022	CcSEcCtD
Efavirenz—Insomnia—Ramipril—coronary artery disease	2.58e-05	0.00022	CcSEcCtD
Efavirenz—Dermatitis—Olmesartan—coronary artery disease	2.58e-05	0.00022	CcSEcCtD
Efavirenz—Headache—Valsartan—coronary artery disease	2.57e-05	0.00022	CcSEcCtD
Efavirenz—Diarrhoea—Telmisartan—coronary artery disease	2.57e-05	0.000219	CcSEcCtD
Efavirenz—Headache—Olmesartan—coronary artery disease	2.56e-05	0.000219	CcSEcCtD
Efavirenz—Paraesthesia—Ramipril—coronary artery disease	2.56e-05	0.000219	CcSEcCtD
Efavirenz—Shock—Lisinopril—coronary artery disease	2.54e-05	0.000217	CcSEcCtD
Efavirenz—Asthenia—Perindopril—coronary artery disease	2.54e-05	0.000217	CcSEcCtD
Efavirenz—Dyspnoea—Ramipril—coronary artery disease	2.54e-05	0.000217	CcSEcCtD
Efavirenz—Vomiting—Niacin—coronary artery disease	2.54e-05	0.000217	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Timolol—coronary artery disease	2.54e-05	0.000217	CcSEcCtD
Efavirenz—Hypersensitivity—Furosemide—coronary artery disease	2.54e-05	0.000217	CcSEcCtD
Efavirenz—Somnolence—Ramipril—coronary artery disease	2.53e-05	0.000217	CcSEcCtD
Efavirenz—Thrombocytopenia—Lisinopril—coronary artery disease	2.53e-05	0.000216	CcSEcCtD
Efavirenz—Dizziness—Trandolapril—coronary artery disease	2.53e-05	0.000216	CcSEcCtD
Efavirenz—Tachycardia—Lisinopril—coronary artery disease	2.52e-05	0.000216	CcSEcCtD
Efavirenz—Insomnia—Timolol—coronary artery disease	2.52e-05	0.000215	CcSEcCtD
Efavirenz—Rash—Niacin—coronary artery disease	2.52e-05	0.000215	CcSEcCtD
Efavirenz—Dermatitis—Niacin—coronary artery disease	2.52e-05	0.000215	CcSEcCtD
Efavirenz—Dizziness—Enalapril—coronary artery disease	2.52e-05	0.000215	CcSEcCtD
Efavirenz—Skin disorder—Lisinopril—coronary artery disease	2.51e-05	0.000215	CcSEcCtD
Efavirenz—Dyspepsia—Ramipril—coronary artery disease	2.51e-05	0.000214	CcSEcCtD
Efavirenz—Pruritus—Perindopril—coronary artery disease	2.51e-05	0.000214	CcSEcCtD
Efavirenz—Headache—Niacin—coronary artery disease	2.5e-05	0.000214	CcSEcCtD
Efavirenz—Paraesthesia—Timolol—coronary artery disease	2.5e-05	0.000214	CcSEcCtD
Efavirenz—Vomiting—Pravastatin—coronary artery disease	2.5e-05	0.000214	CcSEcCtD
Efavirenz—Hyperhidrosis—Lisinopril—coronary artery disease	2.5e-05	0.000214	CcSEcCtD
Efavirenz—Diarrhoea—Captopril—coronary artery disease	2.5e-05	0.000213	CcSEcCtD
Efavirenz—Dyspnoea—Timolol—coronary artery disease	2.48e-05	0.000212	CcSEcCtD
Efavirenz—Dizziness—Telmisartan—coronary artery disease	2.48e-05	0.000212	CcSEcCtD
Efavirenz—Rash—Pravastatin—coronary artery disease	2.48e-05	0.000212	CcSEcCtD
Efavirenz—Dermatitis—Pravastatin—coronary artery disease	2.48e-05	0.000212	CcSEcCtD
Efavirenz—Decreased appetite—Ramipril—coronary artery disease	2.48e-05	0.000212	CcSEcCtD
Efavirenz—Somnolence—Timolol—coronary artery disease	2.48e-05	0.000212	CcSEcCtD
Efavirenz—Asthenia—Furosemide—coronary artery disease	2.47e-05	0.000211	CcSEcCtD
Efavirenz—Headache—Pravastatin—coronary artery disease	2.46e-05	0.000211	CcSEcCtD
Efavirenz—Anorexia—Lisinopril—coronary artery disease	2.46e-05	0.000211	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Ramipril—coronary artery disease	2.46e-05	0.00021	CcSEcCtD
Efavirenz—Fatigue—Ramipril—coronary artery disease	2.46e-05	0.00021	CcSEcCtD
Efavirenz—Dyspepsia—Timolol—coronary artery disease	2.45e-05	0.00021	CcSEcCtD
Efavirenz—Hypersensitivity—Losartan—coronary artery disease	2.45e-05	0.000209	CcSEcCtD
Efavirenz—Nausea—Valsartan—coronary artery disease	2.44e-05	0.000209	CcSEcCtD
Efavirenz—Pruritus—Furosemide—coronary artery disease	2.44e-05	0.000208	CcSEcCtD
Efavirenz—Constipation—Ramipril—coronary artery disease	2.44e-05	0.000208	CcSEcCtD
Efavirenz—Nausea—Olmesartan—coronary artery disease	2.43e-05	0.000208	CcSEcCtD
Efavirenz—Vomiting—Trandolapril—coronary artery disease	2.43e-05	0.000208	CcSEcCtD
Efavirenz—Diarrhoea—Perindopril—coronary artery disease	2.42e-05	0.000207	CcSEcCtD
Efavirenz—Decreased appetite—Timolol—coronary artery disease	2.42e-05	0.000207	CcSEcCtD
Efavirenz—Vomiting—Enalapril—coronary artery disease	2.42e-05	0.000207	CcSEcCtD
Efavirenz—Dizziness—Captopril—coronary artery disease	2.41e-05	0.000206	CcSEcCtD
Efavirenz—Rash—Trandolapril—coronary artery disease	2.41e-05	0.000206	CcSEcCtD
Efavirenz—Dermatitis—Trandolapril—coronary artery disease	2.41e-05	0.000206	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Timolol—coronary artery disease	2.41e-05	0.000206	CcSEcCtD
Efavirenz—Fatigue—Timolol—coronary artery disease	2.4e-05	0.000205	CcSEcCtD
Efavirenz—Rash—Enalapril—coronary artery disease	2.4e-05	0.000205	CcSEcCtD
Efavirenz—Dermatitis—Enalapril—coronary artery disease	2.4e-05	0.000205	CcSEcCtD
Efavirenz—Headache—Trandolapril—coronary artery disease	2.39e-05	0.000205	CcSEcCtD
Efavirenz—Vomiting—Telmisartan—coronary artery disease	2.39e-05	0.000204	CcSEcCtD
Efavirenz—Asthenia—Losartan—coronary artery disease	2.38e-05	0.000204	CcSEcCtD
Efavirenz—Headache—Enalapril—coronary artery disease	2.38e-05	0.000204	CcSEcCtD
Efavirenz—Pain—Timolol—coronary artery disease	2.38e-05	0.000204	CcSEcCtD
Efavirenz—Nausea—Niacin—coronary artery disease	2.37e-05	0.000203	CcSEcCtD
Efavirenz—Rash—Telmisartan—coronary artery disease	2.37e-05	0.000202	CcSEcCtD
Efavirenz—Dermatitis—Telmisartan—coronary artery disease	2.36e-05	0.000202	CcSEcCtD
Efavirenz—Diarrhoea—Furosemide—coronary artery disease	2.36e-05	0.000201	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.36e-05	0.000201	CcSEcCtD
Efavirenz—Pruritus—Losartan—coronary artery disease	2.35e-05	0.000201	CcSEcCtD
Efavirenz—Headache—Telmisartan—coronary artery disease	2.35e-05	0.000201	CcSEcCtD
Efavirenz—Feeling abnormal—Ramipril—coronary artery disease	2.35e-05	0.000201	CcSEcCtD
Efavirenz—Dizziness—Perindopril—coronary artery disease	2.34e-05	0.0002	CcSEcCtD
Efavirenz—Insomnia—Lisinopril—coronary artery disease	2.34e-05	0.0002	CcSEcCtD
Efavirenz—Nausea—Pravastatin—coronary artery disease	2.34e-05	0.0002	CcSEcCtD
Efavirenz—Gastrointestinal pain—Ramipril—coronary artery disease	2.33e-05	0.000199	CcSEcCtD
Efavirenz—Paraesthesia—Lisinopril—coronary artery disease	2.32e-05	0.000198	CcSEcCtD
Efavirenz—Vomiting—Captopril—coronary artery disease	2.32e-05	0.000198	CcSEcCtD
Efavirenz—Dyspnoea—Lisinopril—coronary artery disease	2.3e-05	0.000197	CcSEcCtD
Efavirenz—Rash—Captopril—coronary artery disease	2.3e-05	0.000197	CcSEcCtD
Efavirenz—Dermatitis—Captopril—coronary artery disease	2.3e-05	0.000196	CcSEcCtD
Efavirenz—Somnolence—Lisinopril—coronary artery disease	2.3e-05	0.000196	CcSEcCtD
Efavirenz—Feeling abnormal—Timolol—coronary artery disease	2.3e-05	0.000196	CcSEcCtD
Efavirenz—Headache—Captopril—coronary artery disease	2.29e-05	0.000195	CcSEcCtD
Efavirenz—Gastrointestinal pain—Timolol—coronary artery disease	2.28e-05	0.000195	CcSEcCtD
Efavirenz—Dizziness—Furosemide—coronary artery disease	2.28e-05	0.000195	CcSEcCtD
Efavirenz—Dyspepsia—Lisinopril—coronary artery disease	2.28e-05	0.000194	CcSEcCtD
Efavirenz—Diarrhoea—Losartan—coronary artery disease	2.27e-05	0.000194	CcSEcCtD
Efavirenz—Nausea—Trandolapril—coronary artery disease	2.27e-05	0.000194	CcSEcCtD
Efavirenz—Urticaria—Ramipril—coronary artery disease	2.26e-05	0.000193	CcSEcCtD
Efavirenz—Nausea—Enalapril—coronary artery disease	2.26e-05	0.000193	CcSEcCtD
Efavirenz—Vomiting—Perindopril—coronary artery disease	2.25e-05	0.000193	CcSEcCtD
Efavirenz—Body temperature increased—Ramipril—coronary artery disease	2.25e-05	0.000193	CcSEcCtD
Efavirenz—Abdominal pain—Ramipril—coronary artery disease	2.25e-05	0.000193	CcSEcCtD
Efavirenz—Decreased appetite—Lisinopril—coronary artery disease	2.25e-05	0.000192	CcSEcCtD
Efavirenz—Rash—Perindopril—coronary artery disease	2.23e-05	0.000191	CcSEcCtD
Efavirenz—Dermatitis—Perindopril—coronary artery disease	2.23e-05	0.000191	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.23e-05	0.000191	CcSEcCtD
Efavirenz—Nausea—Telmisartan—coronary artery disease	2.23e-05	0.000191	CcSEcCtD
Efavirenz—Fatigue—Lisinopril—coronary artery disease	2.23e-05	0.00019	CcSEcCtD
Efavirenz—Headache—Perindopril—coronary artery disease	2.22e-05	0.00019	CcSEcCtD
Efavirenz—Urticaria—Timolol—coronary artery disease	2.21e-05	0.000189	CcSEcCtD
Efavirenz—Pain—Lisinopril—coronary artery disease	2.21e-05	0.000189	CcSEcCtD
Efavirenz—Constipation—Lisinopril—coronary artery disease	2.21e-05	0.000189	CcSEcCtD
Efavirenz—Body temperature increased—Timolol—coronary artery disease	2.2e-05	0.000188	CcSEcCtD
Efavirenz—Abdominal pain—Timolol—coronary artery disease	2.2e-05	0.000188	CcSEcCtD
Efavirenz—Dizziness—Losartan—coronary artery disease	2.2e-05	0.000188	CcSEcCtD
Efavirenz—Vomiting—Furosemide—coronary artery disease	2.19e-05	0.000187	CcSEcCtD
Efavirenz—Rash—Furosemide—coronary artery disease	2.17e-05	0.000186	CcSEcCtD
Efavirenz—Dermatitis—Furosemide—coronary artery disease	2.17e-05	0.000185	CcSEcCtD
Efavirenz—Nausea—Captopril—coronary artery disease	2.17e-05	0.000185	CcSEcCtD
Efavirenz—Headache—Furosemide—coronary artery disease	2.16e-05	0.000184	CcSEcCtD
Efavirenz—Feeling abnormal—Lisinopril—coronary artery disease	2.13e-05	0.000182	CcSEcCtD
Efavirenz—Gastrointestinal pain—Lisinopril—coronary artery disease	2.11e-05	0.000181	CcSEcCtD
Efavirenz—Vomiting—Losartan—coronary artery disease	2.11e-05	0.000181	CcSEcCtD
Efavirenz—Nausea—Perindopril—coronary artery disease	2.11e-05	0.00018	CcSEcCtD
Efavirenz—Hypersensitivity—Ramipril—coronary artery disease	2.1e-05	0.000179	CcSEcCtD
Efavirenz—Rash—Losartan—coronary artery disease	2.1e-05	0.000179	CcSEcCtD
Efavirenz—Dermatitis—Losartan—coronary artery disease	2.09e-05	0.000179	CcSEcCtD
Efavirenz—Headache—Losartan—coronary artery disease	2.08e-05	0.000178	CcSEcCtD
Efavirenz—Urticaria—Lisinopril—coronary artery disease	2.05e-05	0.000175	CcSEcCtD
Efavirenz—Hypersensitivity—Timolol—coronary artery disease	2.05e-05	0.000175	CcSEcCtD
Efavirenz—Nausea—Furosemide—coronary artery disease	2.05e-05	0.000175	CcSEcCtD
Efavirenz—Asthenia—Ramipril—coronary artery disease	2.05e-05	0.000175	CcSEcCtD
Efavirenz—Abdominal pain—Lisinopril—coronary artery disease	2.04e-05	0.000175	CcSEcCtD
Efavirenz—Body temperature increased—Lisinopril—coronary artery disease	2.04e-05	0.000175	CcSEcCtD
Efavirenz—Pruritus—Ramipril—coronary artery disease	2.02e-05	0.000172	CcSEcCtD
Efavirenz—Asthenia—Timolol—coronary artery disease	2e-05	0.000171	CcSEcCtD
Efavirenz—Nausea—Losartan—coronary artery disease	1.97e-05	0.000169	CcSEcCtD
Efavirenz—Pruritus—Timolol—coronary artery disease	1.97e-05	0.000168	CcSEcCtD
Efavirenz—Diarrhoea—Ramipril—coronary artery disease	1.95e-05	0.000167	CcSEcCtD
Efavirenz—Diarrhoea—Timolol—coronary artery disease	1.91e-05	0.000163	CcSEcCtD
Efavirenz—Hypersensitivity—Lisinopril—coronary artery disease	1.9e-05	0.000163	CcSEcCtD
Efavirenz—Dizziness—Ramipril—coronary artery disease	1.88e-05	0.000161	CcSEcCtD
Efavirenz—Asthenia—Lisinopril—coronary artery disease	1.85e-05	0.000158	CcSEcCtD
Efavirenz—Dizziness—Timolol—coronary artery disease	1.84e-05	0.000157	CcSEcCtD
Efavirenz—Pruritus—Lisinopril—coronary artery disease	1.83e-05	0.000156	CcSEcCtD
Efavirenz—Vomiting—Ramipril—coronary artery disease	1.81e-05	0.000155	CcSEcCtD
Efavirenz—Rash—Ramipril—coronary artery disease	1.8e-05	0.000154	CcSEcCtD
Efavirenz—Dermatitis—Ramipril—coronary artery disease	1.8e-05	0.000153	CcSEcCtD
Efavirenz—Headache—Ramipril—coronary artery disease	1.79e-05	0.000153	CcSEcCtD
Efavirenz—Vomiting—Timolol—coronary artery disease	1.77e-05	0.000151	CcSEcCtD
Efavirenz—Diarrhoea—Lisinopril—coronary artery disease	1.77e-05	0.000151	CcSEcCtD
Efavirenz—Rash—Timolol—coronary artery disease	1.76e-05	0.00015	CcSEcCtD
Efavirenz—Dermatitis—Timolol—coronary artery disease	1.76e-05	0.00015	CcSEcCtD
Efavirenz—Headache—Timolol—coronary artery disease	1.75e-05	0.000149	CcSEcCtD
Efavirenz—Dizziness—Lisinopril—coronary artery disease	1.71e-05	0.000146	CcSEcCtD
Efavirenz—Nausea—Ramipril—coronary artery disease	1.69e-05	0.000145	CcSEcCtD
Efavirenz—Nausea—Timolol—coronary artery disease	1.66e-05	0.000141	CcSEcCtD
Efavirenz—Vomiting—Lisinopril—coronary artery disease	1.64e-05	0.00014	CcSEcCtD
Efavirenz—Rash—Lisinopril—coronary artery disease	1.63e-05	0.000139	CcSEcCtD
Efavirenz—Dermatitis—Lisinopril—coronary artery disease	1.63e-05	0.000139	CcSEcCtD
Efavirenz—Headache—Lisinopril—coronary artery disease	1.62e-05	0.000138	CcSEcCtD
Efavirenz—Nausea—Lisinopril—coronary artery disease	1.54e-05	0.000131	CcSEcCtD
Efavirenz—CYP2D6—Metabolism—LDLR—coronary artery disease	3.2e-06	0.000149	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—APOC3—coronary artery disease	3.19e-06	0.000148	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	3.19e-06	0.000148	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PSMB5—coronary artery disease	3.17e-06	0.000148	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PSMA6—coronary artery disease	3.17e-06	0.000148	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—LDLR—coronary artery disease	3.17e-06	0.000148	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	3.17e-06	0.000147	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.17e-06	0.000147	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTT1—coronary artery disease	3.16e-06	0.000147	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SLC9A1—coronary artery disease	3.16e-06	0.000147	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTP1—coronary artery disease	3.15e-06	0.000147	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	3.15e-06	0.000147	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PDHA1—coronary artery disease	3.13e-06	0.000146	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GCLM—coronary artery disease	3.13e-06	0.000146	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTT1—coronary artery disease	3.13e-06	0.000146	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SLC9A1—coronary artery disease	3.13e-06	0.000146	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GCLC—coronary artery disease	3.12e-06	0.000145	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CETP—coronary artery disease	3.12e-06	0.000145	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PPARGC1A—coronary artery disease	3.12e-06	0.000145	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	3.11e-06	0.000145	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—HMOX1—coronary artery disease	3.11e-06	0.000145	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CTGF—coronary artery disease	3.1e-06	0.000144	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CETP—coronary artery disease	3.1e-06	0.000144	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GCLC—coronary artery disease	3.1e-06	0.000144	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—SDC1—coronary artery disease	3.09e-06	0.000144	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—HMGCR—coronary artery disease	3.07e-06	0.000143	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GOT2—coronary artery disease	3.07e-06	0.000143	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CAT—coronary artery disease	3.07e-06	0.000143	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—SDC1—coronary artery disease	3.06e-06	0.000143	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP11B2—coronary artery disease	3.03e-06	0.000141	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—TXNRD1—coronary artery disease	3.03e-06	0.000141	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—VCAN—coronary artery disease	3e-06	0.00014	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC22A3—coronary artery disease	2.99e-06	0.000139	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALDOA—coronary artery disease	2.98e-06	0.000139	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—APOB—coronary artery disease	2.98e-06	0.000139	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ARNTL—coronary artery disease	2.95e-06	0.000137	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HADH—coronary artery disease	2.95e-06	0.000137	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PSMB5—coronary artery disease	2.92e-06	0.000136	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PSMA6—coronary artery disease	2.92e-06	0.000136	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GSTM1—coronary artery disease	2.9e-06	0.000135	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—DCN—coronary artery disease	2.89e-06	0.000135	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PSMB5—coronary artery disease	2.89e-06	0.000135	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PSMA6—coronary artery disease	2.89e-06	0.000135	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	2.89e-06	0.000134	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CTGF—coronary artery disease	2.85e-06	0.000133	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—LPL—coronary artery disease	2.84e-06	0.000132	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CTGF—coronary artery disease	2.82e-06	0.000132	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—HMGCR—coronary artery disease	2.82e-06	0.000132	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GOT2—coronary artery disease	2.82e-06	0.000132	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PLCB1—coronary artery disease	2.82e-06	0.000131	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALDH2—coronary artery disease	2.81e-06	0.000131	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—HMGCR—coronary artery disease	2.8e-06	0.00013	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GOT2—coronary artery disease	2.8e-06	0.00013	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	2.79e-06	0.00013	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—APOA2—coronary artery disease	2.79e-06	0.00013	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GPX2—coronary artery disease	2.79e-06	0.00013	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—GPX1—coronary artery disease	2.77e-06	0.000129	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.77e-06	0.000129	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GPX4—coronary artery disease	2.76e-06	0.000128	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HK1—coronary artery disease	2.76e-06	0.000128	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ABCG5—coronary artery disease	2.76e-06	0.000128	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SULT1A1—coronary artery disease	2.76e-06	0.000128	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	2.74e-06	0.000128	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—LIPC—coronary artery disease	2.74e-06	0.000128	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HBA1—coronary artery disease	2.74e-06	0.000128	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CYP2C19—coronary artery disease	2.74e-06	0.000128	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	2.74e-06	0.000128	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ABCA1—coronary artery disease	2.74e-06	0.000127	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HADHA—coronary artery disease	2.73e-06	0.000127	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—APOC3—coronary artery disease	2.72e-06	0.000127	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—LDLR—coronary artery disease	2.71e-06	0.000126	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	2.71e-06	0.000126	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—CD36—coronary artery disease	2.7e-06	0.000126	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTA1—coronary artery disease	2.69e-06	0.000125	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTT1—coronary artery disease	2.68e-06	0.000125	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SLC9A1—coronary artery disease	2.68e-06	0.000125	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PPP2CA—coronary artery disease	2.67e-06	0.000124	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—LPA—coronary artery disease	2.66e-06	0.000124	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GGT1—coronary artery disease	2.65e-06	0.000123	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GOT1—coronary artery disease	2.65e-06	0.000123	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GCLC—coronary artery disease	2.65e-06	0.000123	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CETP—coronary artery disease	2.65e-06	0.000123	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—SDC1—coronary artery disease	2.62e-06	0.000122	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PLCB1—coronary artery disease	2.6e-06	0.000121	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PLCB3—coronary artery disease	2.58e-06	0.00012	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PLCB1—coronary artery disease	2.57e-06	0.00012	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—MTHFR—coronary artery disease	2.56e-06	0.000119	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—APOA5—coronary artery disease	2.55e-06	0.000119	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.53e-06	0.000118	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ABCA1—coronary artery disease	2.52e-06	0.000117	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—P4HB—coronary artery disease	2.5e-06	0.000117	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ABCA1—coronary artery disease	2.5e-06	0.000116	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PSMA6—coronary artery disease	2.47e-06	0.000115	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PSMB5—coronary artery disease	2.47e-06	0.000115	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	2.47e-06	0.000115	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.46e-06	0.000114	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GOT1—coronary artery disease	2.44e-06	0.000114	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GGT1—coronary artery disease	2.44e-06	0.000114	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—AGT—coronary artery disease	2.43e-06	0.000113	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GGT1—coronary artery disease	2.42e-06	0.000113	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GOT1—coronary artery disease	2.42e-06	0.000113	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CTGF—coronary artery disease	2.41e-06	0.000112	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HMGCR—coronary artery disease	2.39e-06	0.000111	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GOT2—coronary artery disease	2.39e-06	0.000111	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—APOE—coronary artery disease	2.38e-06	0.000111	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTP1—coronary artery disease	2.38e-06	0.000111	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	2.36e-06	0.00011	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—APOA1—coronary artery disease	2.35e-06	0.00011	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—HMOX1—coronary artery disease	2.35e-06	0.000109	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—VCAN—coronary artery disease	2.32e-06	0.000108	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CAT—coronary artery disease	2.32e-06	0.000108	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.3e-06	0.000107	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—APOB—coronary artery disease	2.25e-06	0.000105	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—DCN—coronary artery disease	2.23e-06	0.000104	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PLCB1—coronary artery disease	2.2e-06	0.000102	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTP1—coronary artery disease	2.19e-06	0.000102	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GSTM1—coronary artery disease	2.19e-06	0.000102	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.17e-06	0.000101	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTP1—coronary artery disease	2.17e-06	0.000101	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	2.17e-06	0.000101	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—HMOX1—coronary artery disease	2.16e-06	0.000101	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.16e-06	0.0001	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	2.15e-06	0.0001	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—LPL—coronary artery disease	2.15e-06	0.0001	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—HMOX1—coronary artery disease	2.14e-06	9.97e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ABCA1—coronary artery disease	2.13e-06	9.93e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CAT—coronary artery disease	2.13e-06	9.92e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.12e-06	9.85e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.12e-06	9.85e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—LIPC—coronary artery disease	2.12e-06	9.85e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HBA1—coronary artery disease	2.12e-06	9.85e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CAT—coronary artery disease	2.11e-06	9.84e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—APOC3—coronary artery disease	2.1e-06	9.79e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—GPX1—coronary artery disease	2.1e-06	9.76e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—LDLR—coronary artery disease	2.09e-06	9.73e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PPARG—coronary artery disease	2.07e-06	9.66e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—APOB—coronary artery disease	2.07e-06	9.63e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.07e-06	9.62e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.07e-06	9.62e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GOT1—coronary artery disease	2.07e-06	9.62e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GGT1—coronary artery disease	2.07e-06	9.62e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—APOB—coronary artery disease	2.05e-06	9.55e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—POMC—coronary artery disease	2.05e-06	9.53e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CETP—coronary artery disease	2.04e-06	9.51e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GCLC—coronary artery disease	2.04e-06	9.51e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—CD36—coronary artery disease	2.04e-06	9.5e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—SDC1—coronary artery disease	2.02e-06	9.4e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PPP2CA—coronary artery disease	2.01e-06	9.38e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GSTM1—coronary artery disease	2.01e-06	9.37e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GSTM1—coronary artery disease	1.99e-06	9.29e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—LPL—coronary artery disease	1.98e-06	9.2e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—LPL—coronary artery disease	1.96e-06	9.12e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—MTHFR—coronary artery disease	1.93e-06	9e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—GPX1—coronary artery disease	1.93e-06	8.97e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—GPX1—coronary artery disease	1.91e-06	8.9e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.91e-06	8.88e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.91e-06	8.88e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—CD36—coronary artery disease	1.88e-06	8.74e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—ALB—coronary artery disease	1.87e-06	8.69e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CTGF—coronary artery disease	1.86e-06	8.68e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—CD36—coronary artery disease	1.86e-06	8.66e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTP1—coronary artery disease	1.85e-06	8.64e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PPP2CA—coronary artery disease	1.85e-06	8.63e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GOT2—coronary artery disease	1.85e-06	8.6e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.85e-06	8.6e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	1.84e-06	8.56e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PPP2CA—coronary artery disease	1.84e-06	8.55e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—AGT—coronary artery disease	1.84e-06	8.55e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—HMOX1—coronary artery disease	1.83e-06	8.52e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CAT—coronary artery disease	1.81e-06	8.41e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—APOE—coronary artery disease	1.8e-06	8.38e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—NOS3—coronary artery disease	1.78e-06	8.31e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—APOA1—coronary artery disease	1.78e-06	8.29e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.78e-06	8.28e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.76e-06	8.21e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—APOB—coronary artery disease	1.75e-06	8.16e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GSTM1—coronary artery disease	1.7e-06	7.94e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.7e-06	7.93e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.7e-06	7.91e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—AGT—coronary artery disease	1.69e-06	7.87e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—AGT—coronary artery disease	1.68e-06	7.8e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—LPL—coronary artery disease	1.67e-06	7.79e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—APOE—coronary artery disease	1.66e-06	7.71e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.65e-06	7.66e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—APOE—coronary artery disease	1.64e-06	7.64e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—APOA1—coronary artery disease	1.64e-06	7.62e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—GPX1—coronary artery disease	1.63e-06	7.6e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PTGS2—coronary artery disease	1.63e-06	7.6e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—APOA1—coronary artery disease	1.62e-06	7.56e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GOT1—coronary artery disease	1.59e-06	7.42e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GGT1—coronary artery disease	1.59e-06	7.42e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—CD36—coronary artery disease	1.59e-06	7.4e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PPP2CA—coronary artery disease	1.57e-06	7.31e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PPARG—coronary artery disease	1.57e-06	7.3e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.55e-06	7.23e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—POMC—coronary artery disease	1.55e-06	7.2e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—MTHFR—coronary artery disease	1.51e-06	7.02e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PPARG—coronary artery disease	1.44e-06	6.72e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.43e-06	6.67e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—AGT—coronary artery disease	1.43e-06	6.67e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PPARG—coronary artery disease	1.43e-06	6.66e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—POMC—coronary artery disease	1.42e-06	6.62e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.42e-06	6.6e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.41e-06	6.57e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—POMC—coronary artery disease	1.41e-06	6.57e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—ALB—coronary artery disease	1.41e-06	6.56e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—APOE—coronary artery disease	1.4e-06	6.53e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CAT—coronary artery disease	1.39e-06	6.49e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—APOA1—coronary artery disease	1.39e-06	6.46e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—APOB—coronary artery disease	1.35e-06	6.3e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—NOS3—coronary artery disease	1.35e-06	6.28e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.33e-06	6.18e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.32e-06	6.13e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—ALB—coronary artery disease	1.3e-06	6.04e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—LPL—coronary artery disease	1.29e-06	6.01e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—ALB—coronary artery disease	1.29e-06	5.99e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—GPX1—coronary artery disease	1.26e-06	5.87e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—NOS3—coronary artery disease	1.24e-06	5.78e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PTGS2—coronary artery disease	1.23e-06	5.74e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—NOS3—coronary artery disease	1.23e-06	5.73e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—CD36—coronary artery disease	1.23e-06	5.71e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PPARG—coronary artery disease	1.22e-06	5.69e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.21e-06	5.64e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—POMC—coronary artery disease	1.2e-06	5.61e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.16e-06	5.41e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.13e-06	5.28e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.12e-06	5.24e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—AGT—coronary artery disease	1.1e-06	5.14e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—ALB—coronary artery disease	1.1e-06	5.12e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—APOE—coronary artery disease	1.08e-06	5.04e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—APOA1—coronary artery disease	1.07e-06	4.98e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—NOS3—coronary artery disease	1.05e-06	4.89e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—PIK3CA—coronary artery disease	1e-06	4.68e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PTGS2—coronary artery disease	9.61e-07	4.48e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PPARG—coronary artery disease	9.43e-07	4.39e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—POMC—coronary artery disease	9.3e-07	4.33e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—ALB—coronary artery disease	8.48e-07	3.95e-05	CbGpPWpGaD
Efavirenz—CYP2B6—Metabolism—AKT1—coronary artery disease	8.2e-07	3.82e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—NOS3—coronary artery disease	8.11e-07	3.78e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—PIK3CA—coronary artery disease	7.59e-07	3.53e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PTGS2—coronary artery disease	7.42e-07	3.45e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—PIK3CA—coronary artery disease	6.98e-07	3.25e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—PIK3CA—coronary artery disease	6.92e-07	3.22e-05	CbGpPWpGaD
Efavirenz—CYP2C19—Metabolism—AKT1—coronary artery disease	6.2e-07	2.89e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—PIK3CA—coronary artery disease	5.91e-07	2.75e-05	CbGpPWpGaD
Efavirenz—CYP2D6—Metabolism—AKT1—coronary artery disease	5.7e-07	2.65e-05	CbGpPWpGaD
Efavirenz—CYP2C9—Metabolism—AKT1—coronary artery disease	5.65e-07	2.63e-05	CbGpPWpGaD
Efavirenz—CYP1A2—Metabolism—AKT1—coronary artery disease	4.83e-07	2.25e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—PIK3CA—coronary artery disease	4.56e-07	2.12e-05	CbGpPWpGaD
Efavirenz—CYP3A4—Metabolism—AKT1—coronary artery disease	3.73e-07	1.74e-05	CbGpPWpGaD
